Interim report
Page 1
Results H1-2025 October 2024 – March 2025 Results Q3-2025 October 2024 – June 2025
Page 2
Logista closes the first nine months of 2025 with a 3% increase in Economic Sales Financial Highlights1 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Revenue 9,937 9,480 4.8% Economic Sales 1,361 1,318 3.3% Adjusted EBIT 287 290 (1.1)% Economic Sales Margin 21.1% 22.0% (92) b.p. Operating Profit (EBIT) 245 249 (1.7)% Net Profit 214 237 (9.7)% Macroeconomic context for the period The period has unfolded in a complex macroeconomic and geopolitical environment. On the geopolitical front, the conflict between Russia and Ukraine continues despite failed attempts to reach negotiated solutions. At the same time, the conflict between Israel and Palestine has escalated following the breakdown of the ceasefire in March, with no resolution in sight in the short term, adding further uncertainty to the global context. Furthermore the growing tension between Iran and Western powers, have contributed to prolong uncertainty in the global context. Regarding the macroeconomic environment, the international policy of the new United States government has raised greater concerns about economic growth in the coming months, contributing to increased volatility in commercial transactions. Despite the aforementioned geopolitical situation, it is worth highlighting the significant moderation of inflation in the euro area, which stood at 2.0% year-on-year in June 2025. This development allowed the European Central Bank (ECB) to continue its cycle of interest rate cuts that began in June 2024. At its June 2025 meeting, the ECB reduced rates by another 25 basis points, setting the deposit facility rate at 2.00%, the main refinancing operations rate at 2.15%, and the marginal lending facility rate at 2.40%. Q3-2025 Results 2 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 1 See appendix “Alternative Performance Measures.”
Page 3
Business trend and income statement highlights Consolidated income statement summary2 • Revenues of €9,937 million, + 4.8% vs. last year with increases recorded in Iberia and Italy which more than offset the decline of revenues in France. • Economic Sales of €1,361 million, 3.3% vs. the previous year with improvements in the main businesses of Iberia and Italy. • Adjusted EBIT of €287 million, (1.1)% vs. the previous year. • Adjusted EBIT margin on Economic Sales was 21.1% compared with 22.0% in 2024. • Changes in the value of inventories due to changes in tobacco prices and tobacco taxes during the period in Spain, France and Italy have resulted in an estimated positive impact of € 45 million, vs. €35million in the previous year. • Restructuring Costs of €(3) million vs. €(2) million the year before. • Profit/(loss) from disposal of €6 million, thanks to the sale of various assets in Spain, compared to a profit of €6 million registered after the sale of a French warehouse. • Operating profit of €245 million vs. €249 million in the previous year. • Net financial result of €44 million, vs. €70 million, the year before. • The tax rate of 26.0% vs H1-2024’s tax rate of 25.6%. • Net Profit of €214 million, vs. €237 million during the same period of 2024. 3 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 2 See appendix “Alternative Performance Measures.”
Page 4
Revenue trend (by segment and business)3 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Iberia 3,788 3,515 7.8% Tobacco and related products 3,050 2,794 9.2% Transport 682 673 1.3% Pharmaceutical distribution 230 201 14.5% Other businesses 14 14 (3.1)% Adjustments (187) (167) (11.9)% Italy 3,477 3,224 7.9% Tobacco and others 3,477 3,224 7.9% France 2,717 2,786 (2.5)% Tobacco and related products 2,717 2,786 (2.5)% Adjustments (45) (44) (3.6)% Total Revenues 9,937 9,480 4.8% Economic sales trend (by segment and business)3,4 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Iberia 895 862 3.9% Tobacco and related products 314 288 9.3% Transport 556 551 0.9% Pharmaceutical distribution 84 75 12.0% Other businesses 13 14 (2.6)% Adjustments (73) (66) (10.6)% Italy 322 298 8.0% Tobacco and others 322 298 8.0% France 150 163 (8.5)% Tobacco and related products 150 163 (8.5)% Adjustments (5) (5) (6.2)% Total Economic Sales 1,361 1,318 3.3% 4 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 3 Tobacco and others in Italy includes Logista Pharma Italy 4 See appendix “Alternative Performance Measures.”
Page 5
Adjusted EBIT and EBIT trends 5 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Iberia 149 157 (4.7)% Italy 99 88 12.5% France 38 45 (15.0)% Total adjusted EBIT 287 290 (1.1)% (-) Restructuring costs (3) (2) (50.5)% (-) Depreciation of assets acquired (46) (46) (0.3)% (+/-) Profit/(loss) on disposal and impairment 6 6 3.7% (+/-) Equity-accounted profit/(loss) and other 1 1 4.6% Operating Profit (EBIT ) 245 249 (1.7)% Adjusted Operating Profit (or, Adjusted EBIT) is the main indicator employed by Group Management to analyse and measure business performance. This indicator is essentially calculated by discounting from EBIT costs that are not directly related to the Group’s revenue in each period, which facilitates the analysis of trends in operating costs and in the Group’s margins. The table above sets out the reconciliation of Adjusted EBIT and EBIT for the period under analysis of 2025 and 2024. Amortization of assets from acquisitions includes Logista France, Speedlink, Transportes El Mosca, Carbó Collbatallé, Gramma Farmaceutici and BPS. 5 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 5 See appendix “Alternative Performance Measures.”
Page 6
Segment performance A. Iberia: Spain, Portugal, Poland, The Netherlands and Belgium6,7 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Revenues Iberia 3,788 3,515 7.8% Tobacco and related products 3,050 2,794 9.2% Transport 682 673 1.3% Pharmaceutical distribution 230 201 14.5% Other businesses 14 14 (3.1)% Adjustments (187) (167) (11.9)% Economic Sales Iberia 895 862 3.9% Tobacco and related products 314 288 9.3% Transport 556 551 0.9% Pharmaceutical distribution 84 75 12.0% Other businesses 13 14 (2.6)% Adjustments (73) (66) (10.6)% Revenues of €3,788 million was up by + 7.8% vs.2024. Economic Sales of € 895 million grew by + 3.9% vs 2024. 6 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 6 See appendix “Alternative Performance Measures.” 7 Total volumes distributed include cigarettes, RYO, other and Heat not burned units Tobacco • Economic sales for tobacco and related products grew by 9.3% during the period. • Volumes distributed of cigarettes, plus RYO and others in Iberia have remained stable compared to 2024, after a slight drop in traditional cigarette volumes in Spain of (0.6)% compensated by an increase in cigarettes RYO and others in Portugal. • During the period, there have been variations in retail prices of the main tobacco manufacturers of 0.40€/pack, before the tobacco excise taxes which was effective as of January 1st, 2025. As a consequence, we have estimated a positive impact on results due to variations in the value of inventories of € 34 million (vs.€ 21 million the previous year).
Page 7
7 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 Related Products - Retail • Economic Sales in the distribution of convenience products have grown at single-digit rates. Logista Retail has continued to expand its activity with growth in every distribution channel, with sales increase of its main customers and the incorporation of new clients. • In the retail segment, there has also been significant growth in the distribution of e- cigarette refills and nicotine pouches in Spain, although they continue to represent a very small percentage compared to traditional tobacco. Transport • Revenues of €682 million + 1.3% vs. previous year and Economic sales of € 556 million, + 0.9% vs. 2024. • Economic Sales in long-distance transport reduced due to the decrease in the activity of long distance transport by road. Particularly, Transportes El Mosca’s business has been affected by the macroeconomic situation and a lower demand. Since acquiring full ownership of the company, Logista has strengthened its leadership, implemented its controls and compliance measures, and initiated a cost reduction program to enhance operating performance. Additionally, following Logista’s financial discipline, we are working on improving profitability through different measures, including the client mix by shifting towards clients with international transport needs, while completing the optimization between Logista Freight and El Mosca’s road business. • The parcel segment's Economic Sales posted single-digit growth thanks to an increase in volumes distributed in both the pharmaceutical and food sectors, that offset the decrease in the refrigerated activity at Carbó Collbatallé, where Logista is still working towards improving its profitability. • Economic Sales relating to the courier segment posted single-digit growth, thanks to the incorporation of BPS for the full period and increased shipments in Spain.
Page 8
Adjusted EBIT of €149 million, (4.7)% vs. the previous year. Restructuring Costs of €(3) million vs.€(2) million during 2024. Capital gains or losses on asset sales of €6 million due to the sale of certain assets in Spain vs. capital gains/losses near to zero in the previous year. A Purchase Price Amortization c harge of € (7) million was recognized in the current year due to the acquisition of Speedlink, Transported El Mosca, Carbó and BPS alike the previous fiscal year. Equity-accounted profits and other (book distribution) totalled €1 million vs. € 1 million in the previous year. EBIT of €147 million against €149 million recorded during the previous year. 8 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 Pharmaceutical Distribution • Revenues of € 230 million, + 14.5% vs. previous year and Economic Sales of €84 million, + 12.0%, thanks to the incorporation of new customers, and sales growth in pharmacy channel and in hospitals. Publications Distribution • Revenues reached €14 million and Economic Sales of €13 million, vs. € 14 million and €14 million in the previous year respectively.
Page 9
B. Italy8,9 10 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Revenues Italy 3,477 3,224 7.9% Tobacco and others 3,477 3,224 7.9% Economic Sales Italy 322 298 8.0% Tobacco and others 322 298 8.0% Revenues of €3,477 million, registering an increase of 7.9%, while Economic sales reached €322 million with increases of 8.0% vs. last year thanks to the positive impact of inventory value, improvements in tariffs and increases in the new product categories sales derived from the incorporation of new customers and new added-value services to tobacco manufacturers, that offset the lower volumes. 9 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 8 See appendix “Alternative Performance Measures.” 9 Tobacco and others includes the segment of Logista Pharma Italy 10 Total volumes distributed include cigarettes, RYO, other and Heat not burned units Tobacco • Volumes distributed of cigarettes plus RYO and other declined by (0.5)% vs. the previous year, due to a decline of traditional cigarette volume of (1.7)%, compensate by an increase new product categories and others of 3.1% particularly supported by a growth in heat not burned. • In Italy, there was an increase in excise duties during the period. Furthermore, there were also price increases of tobacco by all mayor tobacco manufacturers. • The variation in the value of inventories as a result of the tobacco price and tax increase has registered an estimated net impact of +€ 8 million vs. c. +€ 6 million in the previous year. • E-cigarette volumes doubled in the period, while nicotine pouches volumes grew strongly, although the latter still account for a small percentage of total volumes in Italy.
Page 10
Adjusted EBIT of €99 million, + 12.5% vs. previous year. Restructuring costs close to zero for both periods. EBIT of €99 million + 12.4% vs. 2024. 10 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 Related Products - Retail • Economic Sales from the distribution of convenience products, have registered double-digit growth compared to the previous year, thanks to the good performance in sales of new generation products such as electronic cigarettes. Pharmaceutical Distribution • In the pharmaceutical distribution segment in Italy, during the year, collaboration agreements with several major clients have been renewed, and agreements have been signed with new clients. • Logista plans to open a new warehouse in northern Italy that will facilitate the growth of the pharmaceutical distribution segment in the country.
Page 11
C. France11,12 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Revenues France 2,717 2,786 (2.5)% Tobacco and related products 2,717 2,786 (2.5)% Economic Sales France 150 163 (8.5)% Tobacco and related products 150 163 (8.5)% Revenues of € 2,717 million, (2.5)% and Economic Sales of € 150 million, (8.5)% vs. the previous year, mainly due to a lower impact of the revaluation of inventories and the reduction in volumes distributed of cigarettes and RYO and others. 11 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 11 See appendix “Alternative Performance Measures.” 12 Total volumes distributed include cigarettes, RYO, other and Heat not burned units Tobacco • The decrease in tobacco volumes distributed in comparison to the previous year amounted to (9.1)% in cigarettes plus RYO and other. • During the period there was an increase in excise duties followed by increases in retail price of the main tobacco manufacturers, resulting in an impact on the value of the inventories of €4 million compared to €8 million during the previous year. Related products - Retail • In the retail segment in France, Strator has continued to expand by incorporating new customers, but sales have shown a decline of the tobacco related products sales. • In the retail segment, it is worth noting the significant growth in e-cigarette refill volumes, although this still represents a very small percentage compared to traditional tobacco.
Page 12
Adjusted EBIT of €38 million, (15.0)% vs. last year Restructuring costs € (1) million vs. zero, during last year. The gain on disposal amounted close to zero, vs.€6 million in the previous year as a result of the sale of a warehouse in France. The same depreciation was recorded for the assets generated in the acquisition of the French business, which amounted to € (39) million in both periods. EBIT of €(1) million vs. €12 million the previous year. 12 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800
Page 13
Financial Trends A. Evolution of Net Financial Results The Group has entered into a reciprocal credit line agreement with its majority shareholder (Imperial Brands Plc.), whereby it lends its surplus cash on a daily basis up to a limit of €3,000 million or receives the cash necessary to meet its payment obligations. The terms of the credit line include: 1. First tranche up to €1,000 million will be remunerated at a fixed rate of 2.865% plus a spread of 0.75%, for a total of 3.615%. 2. Second tranche for balances above €1,000 million and up to €3,000 million, which will be remunerated at a EURIBOR 6-month’s rate plus a spread of 0.75%. Taking into account the fixed rate of 2.865% and the average rate of the 6-month Euribor, the average rate referenced for the period, has been 2.48% to which must be added the marginal rate of 0.75% reaching 3.23% total average rate for the period. During the previous year, the average reference rate for the period was 4.42%, to which the differential of 0.75% should be added totalling 5.17%. The average credit line balance during the period was € 1,815 million vs. € 1,932 million in the previous year. Financial income amounted to € 51 million vs. € 77 million in 2024 . This reduction is mainly due to the drop in reference rates. Financial expenses for the period amounted to €(7) million vs. €(7) million recorded in 2024. Net financial income/(expense) for the period therefore totalled € 44 million, vs the €70 million obtained during the same period of 2024. B. Net Profit13 Restructuring costs of €(3) million during the first nine months of 2025 vs. € (2) million in 2024. A capital gain of € 6 million was recorded due to the sale of certain assets in Spain, compared to € 6 million in the previous year after the sale of a warehouse in France. Financial results have been lower than those obtained in the previous year (€ 44 million vs € 70 million), due to the interest rate reduction, reaching a Profit Before Tax of € 289 million, vs. € 319 million the previous year. Tax rate of 26.0% vs. 25.6% for the same period of 2024. Net Profit of €214 million, vs. €237 million during the previous year. Basic earnings per share amounted to 1.62€ vs. 1.80€, in the previous period, with the number of shares representing capital stock remaining the same. As of June 30 th, 2025, the Company held 745,146 treasury shares ( 0.6% of share capital). Most of these shares were purchased to cover future commitments to deliver shares under long-term executive remuneration plans. The other shares secure the liquidity agreement entered into on January 20th, 2021, with Banco Santander, S.A. 13 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 13 See appendix “Alternative Performance Measures.”
Page 14
C. Cash Flow Earnings before interest, taxes, depreciation, and amortization (EBITDA) remained in line with the previous year, reflecting stable business activity. The decline in financial results, driven by the reduction in interest rates, is the main reason for the (13.0)% decrease in normalized cash flow. The change in working capital during the first nine months of fiscal year 2025 shows a significant positive variation compared to the same period last year, which had been affected by a temporary impact related to tobacco volumes in June 2024. Generally, the seasonal nature of the business leads to a negative variation in working capital during the first half of the year, which typically recovers in the second half, reaching its peak at year-end. The variation in the tax cut-off effect is due to calendar-related timing, as the refund of certain advance payments may occur within a six-month window, occasionally causing them to shift from one fiscal year to another. D. Dividend Policy On July 16 th, 2025, the Board of Directors approved the distribution of an interim dividend for the 2025 financial year, which will be paid on Augu st 28 th and will amount to 74 million euros (€0.56 p er share), equal to the interim dividend paid in the previous year in line with the commitment to distribute the same dividend as in 2024. The General Shareholders' Meeting celebrated on February 5th, 2025, approved the distribution of a final dividend for the financial year 2024 of €203 million (1.53 euros per share), which was paid on 27 February 2025. The total dividend for the 2024 financial year reached an amount of €277 million (€2.09 per share), which represents an increase of 13% compared to the previous year (€1.85 per share) and a payout of 90%. E. Business Outlook14 With the current profit on inventory recorded, Logista estimates that the Adjusted Operating Profit, including the impact of the value of inventories, will be in line with current market expectations for fiscal year 2025. Given the lower results of the transport activity, Logista estimates that the Adjusted Operating Profit excluding the impact on inventory values, will be slightly below that of the fiscal year 2024. In line with Logista's strategic plan, whose essential focus is to bring additional growth and diversification to the current business base, the Company continues to seek acquisition opportunities of complementary and synergistic businesses. In any case, maintaining the dividend policy will remain a priority for Logista. Therefore, the Company is committed to distribute during the fiscal year 2025 at least a dividend equal to that distributed in 2024 of €2.09/share. 14 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 14 See appendix “Alternative Performance Measures.”
Page 15
Appendix Income Statement15 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Revenue 9,937 9,480 4.8% Economic Sales 1,361 1,318 3.3% (-) Operating cost of logistics networks (943) (904) (4.3)% (-) Commercial operating expenses (54) (51) (7.5)% (-) Operating expenditure on research and central offices (77) (74) (5.0)% Total Operating Costs (1,074) (1,028) (4.5)% Adjusted EBIT 287 290 (1.1)% Margin % 21.1% 22.0% (92) b.p. (-) Restructuring costs (3) (2) (50.5)% (-) Depreciation of assets acquired (46) (46) (0.3)% (+/-) Profit/(loss) on disposal and impairment 6 6 3.7% (+/-) Profit/(loss) from equity-accounted companies and other 1 1 4.6% Operating Profit (EBIT) 245 249 (1.7)% (+) Financial income 51 77 (33.6)% (-) Financial expenses (7) (7) (1.1)% Profit/(loss) before tax 289 319 (9.5)% (-) Corporate income tax (75) (82) 8.2% Effective tax rate 26.0% 25.6% (35) b.p. (+/-) Other income/(expenses) – – —% (-) Non-controlling interests – – n.m. Net Profit 214 237 (9.7)% 15 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 15 See appendix “Alternative Performance Measures.”
Page 16
Cash Flow Statement16 M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 Variation EBITDA 376 372 4 Restructuring and other payments (6) (13) 7 Net financial income/(expense) 50 76 (25) Normalised taxes (97) (92) (4) Investment (44) (36) (8) Rent payments (56) (50) (6) Normalised Cash Flow 223 257 (33) Change in working capital (63) (411) 348 Effect of cut-off date on taxes (44) 8 (52) Divestments 11 16 (5) Company acquisitions (M&A) (3) (26) 23 Free Cash Flow 126 (156) 282 16 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800 16 See appendix “Alternative Performance Measures.”
Page 17
Balance Sheet M€ 30 Jun. 2025 30 Sept. 2024 Property, plant and equipment and other fixed assets 493 484 Net long-term financial investments 43 32 Net goodwill 1,012 1,012 Other intangible assets 216 262 Deferred tax assets — — Net inventory 1,867 1,824 Net receivables and other 2,321 2,003 Cash and cash equivalents 2,368 2,464 Held-for-sale assets — — Total Assets 8,320 8,081 Shareholders’ funds 650 641 Non-controlling interests — — Non-current liabilities 248 246 Deferred tax liabilities 184 203 Short-term borrowings 64 81 Short-term provisions 7 10 Trade and other payables 7,167 6,900 Liabilities linked to assets held for sale — — Total Liabilities 8,320 8,081 17 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800
Page 18
Alternative Performance Measures • Economic Sales: equivalent to Gross Profit; used interchangeably by Group Management to refer to the figure obtained by subtracting Raw materials and consumables from Revenue. Group management considers this figure to be a significant measure of the tariff revenue generated by distribution services that provides investors with a useful view of the Group’s financial performance. M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 Revenue 9,937 9,480 Raw materials and consumables (8,576) (8,162) Gross Profit 1,361 1,318 • Adjusted EBIT: This indicator is basically calculated by discounting from EBIT costs that are not directly related to the revenue obtained by the Group in each period, which facilitates the analysis of the Group’s operating cost and margin trends. Adjusted EBIT is the main indicator employed by Group management to analyse and measure business performance. M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 Adjusted EBIT 287 290 (-) Restructuring costs (3) (2) (-) Depreciation of Acquired Assets (46) (46) (+/-) Profit/(loss) on disposal and impairment 6 6 (+/-) Equity-accounted profit/(loss) and other 1 1 EBIT 245 249 18 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800
Page 19
• Adjusted EBIT Margin on Economic Sales : calculated as Adjusted EBIT divided by Economic Sales (or, interchangeably, Gross Profit). This ratio is the main indicator employed by Group Management to analyse and measure the trend in profits obtained from the Group’s ordinary business activities in a certain period. M€ 1 Oct 2024 - 30 Jun 2025 1 Oct 2023 - 30 Jun 2024 % Variation Economic sales 1,361 1,318 3.3% Adjusted EBIT 287 290 (1.1)% Economic Sales Margin 21.1% 22.0% (92) b.p • Operating Costs: this term comprises logistics network costs, commercial expenses, research expenditure and central office expenses that are directly related to the Group’s revenue in each period. It is the main figure used by Group management to analyse and measure cost structure trends. It does not include restructuring costs or depreciation charged on assets derived from the acquisitions, which are not directly related to the Group’s revenue in each period. Each segment’s operating costs exclude corporate centre expenditure, which is however included in the Group’s total operating costs so as to show the operating performance of each geographic area. • Non-Recurring Costs: This term refers to costs which may be incurred in more than one period but are not continuous over time (unlike operating costs) and only affect the accounts at a given moment. This figure helps Group Management to analyse and measure the Group’s business trends during each period. • Recurring Operating Costs: This term refers to costs incurred on a continuous basis that allow the Group’s business to continue and are estimated as total operating costs less the non- recurring costs defined in the previous point. This figure helps Group Management to analyse and measure the Group’s business efficiency. • Restructuring Costs: costs incurred by the Group to enhance operational, administrative or commercial efficiency in the organization, including those related to reorganization, lay-offs and the closure or transfer of warehouses or other facilities. • Non-Recurring Results: this refers to results for the year that are not obtained continuously during the year and affect the accounts at a given time. They are included in EBIT. 19 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800
Page 20
Legal Notice This report has been prepared by Logista Integral, S.A. (“Logista” or “the Company”) for information purposes. It is not an offer or an invitation to buy, sell or exchange shares in the Company, nor does it provide advice or recommendations regarding such shares. This document contains certain statements that constitute or may constitute forward-looking representations about the Company, including financial projections and estimates, and related underlying assumptions. Such statements are no guarantee of future performance or results, are subject to risks, uncertainties and other significant factors outside the control of Logista Integral, so that future events and final results may be materially different from those expressed in such statements. Risks and uncertainties include those identified in documents filed by Logista Integral with various bodies that supervise the securities markets on which the shares are listed, and in particular, the Spanish National Securities Market Commission. Analysts and investors are advised not to rely on such forward-looking representations, which have been made based on information and knowledge available at the date of this report. The Company is not obliged to publish any updates or revisions of the representations made should they be affected by unforeseen changes or events, even if such changes or events clearly show that they will not be fulfilled. Finally, this report may contain unaudited or summarized information. This information is subject to, and must be considered in conjunction with, any information available in the public domain, including, if necessary, any other document issued by Logista Integral that contains more comprehensive information. 20 Investor Relations Contact: investor.relations@logista.com, + 34 91 481 9800